# Evaluating the Safety and Efficacy of PNMR as Treatment for Long COVID

> **NCT07627815** · PHASE2 · RECRUITING · sponsor: **ParagonClinicals Inc.** · enrollment: 82 (estimated)

## Conditions studied

- Long COVID

## Interventions

- **DRUG:** Paragon Novel Metabolic Regulator (PNMR)
- **OTHER:** Dietary and Lifestyle Recommendations

## Key facts

- **NCT ID:** NCT07627815
- **Lead sponsor:** ParagonClinicals Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-05-20
- **Primary completion:** 2026-08-26
- **Final completion:** 2026-12-26
- **Target enrollment:** 82 (ESTIMATED)
- **Last updated:** 2026-06-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07627815

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07627815, "Evaluating the Safety and Efficacy of PNMR as Treatment for Long COVID". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07627815. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*